Repurposing drugs in oncology: From candidate selection to clinical adoption.

Abstract:

:Drug repurposing is a strategy that aims to develop novel cancer treatments through the reuse of existing medicines developed in other disease areas. Such a strategy includes the identification of candidate drugs, clinical development, drug licensing, reimbursement and clinical implementation. This review outlines a literature-based approach to candidate selection with illustrative examples in osteosarcoma, pancreatic cancer and perioperative therapies. Key issues related to the development of clinical trials, drug licensing/approval and clinical adoption are explored to highlight some of the obstacles that must be overcome to successfully repurpose a drug as a new therapeutic option.

journal_name

Semin Cancer Biol

authors

Pantziarka P,Verbaanderd C,Huys I,Bouche G,Meheus L

doi

10.1016/j.semcancer.2020.01.008

subject

Has Abstract

pub_date

2020-01-23 00:00:00

eissn

1044-579X

issn

1096-3650

pii

S1044-579X(20)30011-0

pub_type

杂志文章,评审
  • Critical determinants of metastasis.

    abstract::The major cause of death from cancer is due to metastases that are resistant to conventional therapies. Several reasons account for the failure to treat metastases. First, neoplasms are biologically heterogeneous and contain subpopulations of cells with different angiogenic, invasive, and metastatic properties. Second...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2001.0416

    authors: Fidler IJ

    更新日期:2002-04-01 00:00:00

  • Proteomic research in sarcomas - current status and future opportunities.

    abstract::Sarcomas are a rare group of mesenchymal cancers comprising over 70 different histological subtypes. For the majority of these diseases, the molecular understanding of the basis of their initiation and progression remains unclear. As such, limited clinical progress in prognosis or therapeutic regimens have been made o...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.11.003

    authors: Burns J,Wilding CP,L Jones R,H Huang P

    更新日期:2020-04-01 00:00:00

  • MicroRNAs and immunity: novel players in the regulation of normal immune function and inflammation.

    abstract::The discovery of microRNAs (miRNAs) is one of the major scientific breakthroughs in recent years and has revolutionized the way we look at gene regulation. Although we are still at a very early stage in understanding their impact on immunity, miRNAs are changing the way we think about the development of the immune sys...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2008.01.005

    authors: Sonkoly E,Ståhle M,Pivarcsi A

    更新日期:2008-04-01 00:00:00

  • Dietary flavonoids: Nano delivery and nanoparticles for cancer therapy.

    abstract::Application of nanotechnologies to cancer therapy might increase solubility and/or bioavailability of bioactive compounds of natural or synthetic origin and offers other potential benefits in cancer therapy, including selective targeting. In the present review we aim to evaluate in vivo studies on the anticancer activ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.08.029

    authors: Aiello P,Consalvi S,Poce G,Raguzzini A,Toti E,Palmery M,Biava M,Bernardi M,Kamal MA,Perry G,Peluso I

    更新日期:2019-08-24 00:00:00

  • Aberrations in DNA repair pathways in cancer and therapeutic significances.

    abstract::Cancer cells show various types of mutations and aberrant expression in genes involved in DNA repair responses. These alterations induce genome instability and promote carcinogenesis steps and cancer progression processes. These defects in DNA repair have also been considered as suitable targets for cancer therapies. ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.02.005

    authors: Motegi A,Masutani M,Yoshioka KI,Bessho T

    更新日期:2019-10-01 00:00:00

  • Stress-activated protein kinases-tumor suppressors or tumor initiators?

    abstract::The biology and the pathology of the stress-activated protein kinases (SAPKs; p38s and c-Jun-NH(2)-terminal kinases (JNKs)) are somewhat confusing. In some systems, these enzymes augment cell proliferation whereas in other cells they support growth arrest and tumor suppressing activity. Similarly, in some types of can...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2004.04.006

    authors: Engelberg D

    更新日期:2004-08-01 00:00:00

  • Bioinformatics workflows for clinical applications in precision oncology.

    abstract::High-throughput molecular profiling of tumors is a fundamental aspect of precision oncology, enabling the identification of genomic alterations that can be targeted therapeutically. In this context, a patient is matched to a specific drug or therapy based on the tumor's underlying genetic driver events rather than the...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2020.12.020

    authors: Jäger N

    更新日期:2021-01-18 00:00:00

  • Harnessing serotonergic and dopaminergic pathways for lymphoma therapy: evidence and aspirations.

    abstract::Growing evidence supports the notion that pharmaceutical targeting of the 5-hydroxytryptamine (5-HT) and dopamine (DA) systems offers the potential to treat human immune system disorders. This review describes this emerging area of research, which has the benefit of being supported by a relatively detailed understandi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.007

    authors: Barnes NM,Gordon J

    更新日期:2008-06-01 00:00:00

  • What patents tell us about drug repurposing for cancer: A landscape analysis.

    abstract::Intellectual property documents (patents and their published applications) are not only collections of legal exclusivity claims but also repositories of scientific and technical information, even though they are not peer reviewed. We have identified and analyzed international disclosures concerning drug repurposing fo...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.010

    authors: Mucke HAM

    更新日期:2019-09-20 00:00:00

  • The impact of CD4+CD25+ Treg on tumor specific CD8+ T cell cytotoxicity and cancer.

    abstract::There is sufficient evidence to suggest that tumor growth elicits specific immune responses, including CD8(+) and CD4(+) T cell responses that may delay tumor growth and could potentially be harnessed to eradicate cancer. Nevertheless the frequent outcome of cancer is lethality associated with uncontrolled growth and ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2005.11.006

    authors: Khazaie K,von Boehmer H

    更新日期:2006-04-01 00:00:00

  • Laminin isoforms in tumor invasion, angiogenesis and metastasis.

    abstract::Laminins are a growing family of alphabetagamma heterotrimeric proteins, commonly found in basement membranes (BMs). These large molecules promote cell adhesion and migration via integrins and other cell-surface receptors. Over 12 laminin isoforms are presently known. The various isoforms have a cell- and tissue-speci...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/S1044-579X(02)00023-8

    authors: Patarroyo M,Tryggvason K,Virtanen I

    更新日期:2002-06-01 00:00:00

  • Endogenous opiates, opioids, and immune function: evolutionary brokerage of defensive behaviors.

    abstract::Recent empirical data have elucidated a compelling physiological basis for endogenously expressed, chemically authentic, morphine and its cognate mu3 and mu4 opiate receptors. Cellular "morphinergic" signaling is predominantly targeted to autocrine/paracrine regulatory processes and is reciprocally linked to stimulate...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2007.12.001

    authors: Stefano GB,Kream R

    更新日期:2008-06-01 00:00:00

  • The emerging roles of F-box proteins in pancreatic tumorigenesis.

    abstract::The role of F-box proteins in pancreatic tumorigenesis is emerging owing to their pivotal and indispensable roles in cell differentiation, cell cycle regulation and proliferation. In this review, we will focus on β-TrCP (β-transducin repeat-containing protein) and two other prototypical mammalian F-box proteins, Fbxw7...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2015.09.004

    authors: Wang H,Maitra A,Wang H

    更新日期:2016-02-01 00:00:00

  • Cancer-testis antigens: Unique cancer stem cell biomarkers and targets for cancer therapy.

    abstract::Cancer-testis antigens (CTAs) are considered as unique and promising cancer biomarkers and targets for cancer therapy. CTAs are multifunctional protein group with specific expression patterns in normal embryonic and adult cells and various types of cancer cells. CTAs are involved in regulating of the basic cellular pr...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.08.006

    authors: Gordeeva O

    更新日期:2018-12-01 00:00:00

  • SVA retrotransposons: Evolution and genetic instability.

    abstract::SINE-VNTR-Alus (SVA) are non-autonomous hominid specific retrotransposons that are associated with disease in humans. SVAs are evolutionarily young and presumably mobilized by the LINE-1 reverse transcriptase in trans. SVAs are currently active and may impact the host through a variety of mechanisms including insertio...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.04.001

    authors: Hancks DC,Kazazian HH Jr

    更新日期:2010-08-01 00:00:00

  • Homeostatic interplay between FoxO proteins and ER proteostasis in cancer and other diseases.

    abstract::Cancer cells are exposed to adverse conditions within the tumor microenvironment that challenge cells to adapt and survive. Several of these homeostatic perturbations insults alter the normal function of the endoplasmic reticulum (ER), resulting in the accumulation of misfolded proteins. ER stress triggers a conserved...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.01.011

    authors: González-Quiroz M,Urra H,Limia CM,Hetz C

    更新日期:2018-06-01 00:00:00

  • 3D-extravasation model -- selection of highly motile and metastatic cancer cells.

    abstract::Extravasation has been described as a rate-limiting step in the process of hematogeneous metastasis formation. Thereby, transendothelial migration of tumor cells consists of a complex series of events involving multiple cell-cell and cell-matrix interactions. 3D-extravasation assays are valuable tools for the identifi...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2005.06.006

    authors: Brandt B,Heyder C,Gloria-Maercker E,Hatzmann W,Rötger A,Kemming D,Zänker KS,Entschladen F,Dittmar T

    更新日期:2005-10-01 00:00:00

  • Requirement for reverse immune surveillance for the growth of germinal center-derived murine lymphomas.

    abstract::The concept of reverse immune surveillance, first conceived over 12 years ago, described the relationship that existed between germinal center-derived B cell lymphoma cells and the host immune system in SjL/J mice. According to reverse immune surveillance, recognition of tumor cell antigens and a response by the host ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0330

    authors: Ponzio NM,Thorbecke GJ

    更新日期:2000-10-01 00:00:00

  • The role of NK cell recognition of nectin and nectin-like proteins in tumor immunosurveillance.

    abstract::Natural killer (NK) cells have important functions in the innate immunity to tumors. Recognition of tumor cells by NK cells is mediated by the interaction of activating and inhibitory NK cell receptors with ligands expressed on the tumor target. In addition, NK cell-target cell interactions require the engagement of a...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.07.002

    authors: Fuchs A,Colonna M

    更新日期:2006-10-01 00:00:00

  • Regulation of p53 downstream genes.

    abstract::The p53 tumor suppressor is the most commonly mutated gene in human cancer. p53 protein is stabilized in response to different checkpoints activated by DNA damage, hypoxia, viral infection, or oncogene activation resulting in diverse biological effects, such as cell cycle arrest, apoptosis, senescence, differentiation...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1998.0097

    authors: el-Deiry WS

    更新日期:1998-01-01 00:00:00

  • Molecular bases for the development of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC).

    abstract::Hepatocellular carcinoma (HCC) is the most common histological form of primary liver cancer; the tumor cells having retained features of hepatocytic differentiation. It is important to emphasize the heterogeneity of the histological background on which the tumor develops. Most HCCs complicate the evolution of an activ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.2000.0321

    authors: Bréchot C,Gozuacik D,Murakami Y,Paterlini-Bréchot P

    更新日期:2000-06-01 00:00:00

  • Challenges and opportunities in the proteomic characterization of clear cell renal cell carcinoma (ccRCC): A critical step towards the personalized care of renal cancers.

    abstract::Clear cell renal cell carcinoma (ccRCC) is the most common type of kidney cancer, comprising approximately 75% of all kidney tumors. Recent the Cancer Genome Atlas (TCGA) and International Cancer Genome Consortium (ICGC) studies have significantly advanced the molecular characterization of RCC and facilitated the deve...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.06.004

    authors: Li QK,Pavlovich CP,Zhang H,Kinsinger CR,Chan DW

    更新日期:2019-04-01 00:00:00

  • The genomic risk of somatic gene therapy.

    abstract::Gene vectors with an untargeted insertion profile have been explored in preclinical models and clinical trials for the transfer of potentially therapeutic genetic information into somatic cells that have a high replicative potential. The gene-modified cell population can be viewed as a genetic mosaic whose complexity ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2010.06.003

    authors: Kustikova O,Brugman M,Baum C

    更新日期:2010-08-01 00:00:00

  • The roles of sirtuins family in cell metabolism during tumor development.

    abstract::Altering energy metabolism to meet the uncontrolled proliferation and metastasis has emerged as one of the most significant hallmarks in tumors. However, the detailed molecular mechanisms and regulatory actions underlying have not been fully elucidated. As a family of NAD+ dependent protein modifying enzymes, sirtuins...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2018.11.003

    authors: Zhu S,Dong Z,Ke X,Hou J,Zhao E,Zhang K,Wang F,Yang L,Xiang Z,Cui H

    更新日期:2019-08-01 00:00:00

  • Current and future systemic treatments for renal cell carcinoma.

    abstract::Systemic treatment of renal cell carcinoma has changed dramatically since 2007, with the development and approval of six new agents, which target complex molecular pathways regulating tumour angiogenesis and cell proliferation and survival. These treatments have significantly improved survival times in metastatic rena...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2012.06.004

    authors: Fisher R,Gore M,Larkin J

    更新日期:2013-02-01 00:00:00

  • Epigenetic deregulation in cancer: Enzyme players and non-coding RNAs.

    abstract::Data obtained from cutting-edge research have shown that deregulated epigenetic marks are critical hallmarks of cancer. Rapidly emerging scientific evidence has helped in developing a proper understanding of the mechanisms leading to control of cellular functions, from changes in chromatin accessibility, transcription...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章

    doi:10.1016/j.semcancer.2020.07.013

    authors: Farooqi AA,Fayyaz S,Poltronieri P,Calin G,Mallardo M

    更新日期:2020-07-30 00:00:00

  • The role of exosomes in cancer metastasis.

    abstract::Exosomes are small membrane vesicles with a size ranging from 40 to 100nm. They can serve as functional mediators in cell interaction leading to cancer metastasis. Metastasis is a complex multistep process of cancer cell invasion, survival in blood vessels, attachment to and colonization of the host organ. Exosomes in...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2017.02.006

    authors: Steinbichler TB,Dudás J,Riechelmann H,Skvortsova II

    更新日期:2017-06-01 00:00:00

  • Molecular mechanistic insights: The emerging role of SOXF transcription factors in tumorigenesis and development.

    abstract::Over the last decade, the development and progress of next-generation sequencers incorporated with classical biochemical analyses have drastically produced novel insights into transcription factors, including Sry-like high-mobility group box (SOX) factors. In addition to their primary functions in binding to and activ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2019.09.008

    authors: Higashijima Y,Kanki Y

    更新日期:2020-12-01 00:00:00

  • Xpa knockout mice.

    abstract::The xeroderma pigmentosum group A correcting (XPA) gene encodes a DNA binding zinc-finger protein that recognizes DNA damage. As such the XPA protein participates in the initial step of the process of nucleotide excision repair. The multicomponent nucleotide excision repair pathway is one of the most thoroughly studie...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1006/scbi.1996.0031

    authors: de Vries A,van Steeg H

    更新日期:1996-10-01 00:00:00

  • Specificity, selection and significance of gene amplifications in cancer.

    abstract::DNA copy number amplifications activate oncogenes and are found in the majority of advanced solid tumors. Cell-lineage specificity and oncogene affinity of DNA amplifications in cancer suggest that properties of precursor stem cells and selection pressure in the tissue micro-environment determine the genomic location ...

    journal_title:Seminars in cancer biology

    pub_type: 杂志文章,评审

    doi:10.1016/j.semcancer.2006.10.005

    authors: Myllykangas S,Böhling T,Knuutila S

    更新日期:2007-02-01 00:00:00